Renasant Corporation
NYSE:RNSTBanks - Regional
+$0.46 today
- Market cap
- $3.58B
- Beta
- 0.99
- P/E (TTM)
- 17.1
- EPS (TTM)
- $2.43
- Dividend yield
- 2.21%
Volume 0.75M
Average 0.69M
RNST Common Stock
The par or stated value of issued common shares, plus paid-in capital where reported together.
Renasant CorporationNYSE: RNST
Common Stock · Q3 FY2026 · quarter ended Sep 2026
Common stock broadly unchanged from a year ago
Common stock stood at $488.61M at the end of Q3 FY2026, up 0.0% from a year earlier and up 0.0% from the prior quarter. Over 3 fiscal years it compounded at +18.1% a year.
Context
- Common stock amounted to 1.8% of total assets at the end of Q3 FY2026, unchanged from a year earlier.
- Common stock increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether common stock keeps rising in the next quarterly balance sheet after a +0.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Common Stock history
USD · from the balance sheet
- Latest · FY2025
- 488.61M USD
- Year-over-year change
- +47.0%
- 4-year CAGR
- +13.3%
| Period | Period end | Common Stock | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 488.61M | +47.0% |
| FY2024 | 2024-12-31 | 332.42M | +12.1% |
| FY2023 | 2023-12-31 | 296.48M | +0.0% |
| FY2022 | 2022-12-31 | 296.48M | +0.0% |
| FY2021 | 2021-12-31 | 296.48M | — |
Common Stock vs competitors
How RNST compares with its peers on the latest reported figures
- RNST's Sep 2026 common stock of $488.61M is the 4th highest of the 11 companies compared; the peer median is $11.9M.
- Its year-over-year change of +0.0% is the 5th highest of 11, against a peer median of -2.8%.
- Common stock amounts to 1.8% of total assets for RNST, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Jun 2026 | $9.48B | +518322.9% | +0.0% | 11.0% | |
| Sep 2026 | $5.28B | +279345.5% | +2.6% | 10.3% | |
| Sep 2026 | $2.13B | -12.9% | -1.7% | 8.2% | |
| Sep 2026 | $488.61M | +0.0% | +18.1% | 1.8% | |
| Jun 2026 | $55.07M | +0.3% | +0.4% | 0.3% | |
| Sep 2026 | $22.37M | +0.0% | +0.0% | 0.1% | |
| Sep 2026 | $1.43M | +0.4% | +0.3% | 0.0% | |
| Sep 2026 | $702K | -6.6% | -0.7% | 0.0% | |
| Sep 2026 | $467K | -5.7% | +2.5% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +3.2% | 0.0% | |
| Sep 2026 | $0 | -100.0% | +0.3% | 0.0% | |
| Peer median (excluding RNST) | $11.9M | -2.8% | +0.3% | 0.1% | |
Competitors are the stored peer set for RNST. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 1.88B | 575.99M | 801.35M | 1.09B | 1.07B |
| Short-term Investments | 2.39B | 1.53B | 923.28M | 831.01M | 0 |
| Net Receivables | 74.64M | 112.55M | 113.51M | 87.22M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 4.34B | 2.22B | 1.84B | 2.01B | 1.07B |
| Property, Plant & Equipment (Net) | 293.12M | 283.6M | 283.2M | 279.8M | 465.14M |
| Goodwill | 939.68M | 991.71M | 991.67M | 988.9M | 1.41B |
| Intangible Assets | 113.12M | 108.62M | 110.48M | 87.1M | 146.61M |
| Long-term Investments | 10.65B | 12.71B | 13.44B | 13.97B | 22.63B |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 473.74M | 673.96M | 696.69M | 700.49M | 1.04B |
| Total Non-current Assets | 12.47B | 14.77B | 15.52B | 16.02B | 25.68B |
| Total Assets | 16.81B | 16.99B | 17.36B | 18.03B | 26.75B |
| Account Payables | 0 | 0 | 0 | 0 | 0 |
| Short-term Debt | 13.95M | 712.23M | 307.58M | 108.02M | 555.77M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 13.91B | 13.49B | 14.08B | 14.57B | 0 |
| Total Current Liabilities | 13.92B | 14.2B | 14.38B | 14.68B | 555.77M |
| Long-term Debt | 471.21M | 428.13M | 429.4M | 430.61M | 499.76M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 209.58M | 224.83M | 249.39M | 245.31M | 21.81B |
| Total Non-current Liabilities | 680.79M | 652.96M | 678.79M | 675.92M | 22.31B |
| Total Liabilities | 14.6B | 14.85B | 15.06B | 15.36B | 22.87B |
| Common Stock | 296.48M | 296.48M | 296.48M | 332.42M | 488.61M |
| Retained Earnings | 741.65M | 857.73M | 952.12M | 1.09B | 1.2B |
| Accumulated OCI | (10.44M) | (209.04M) | (154.26M) | (142.61M) | (89.73M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 2.21B | 2.14B | 2.3B | 2.68B | 3.88B |
| Total Debt | 485.16M | 1.14B | 736.98M | 538.63M | 1.06B |
| Net Debt | (1.39B) | 564.37M | (64.37M) | (553.4M) | (15.19M) |
Renasant Corporation
NYSE:RNST
Intrinsic Alpha fair value
Locked
Current Price
$39.68
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.